ARQ vs ASTH

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 03, 2026

ARQ

49.2
AI Score
VS
ASTH Wins

ASTH

60.0
AI Score

Investment Advisor Scores

ARQ

49score
Recommendation
HOLD

ASTH

60score
Recommendation
BUY

AI Analyst Insights

Detailed Metrics Comparison

Metric ARQ ASTH Winner
Forward P/E 55.8659 23.0415 ASTH
PEG Ratio 11.7462 0 Tie
Revenue Growth 6.6% 55.6% ASTH
Earnings Growth 0.0% 110.1% ASTH
Tradestie Score 49.2/100 60.0/100 ASTH
Profit Margin -43.9% 0.9% ASTH
Beta 1.00 1.00 Tie
AI Recommendation HOLD BUY ASTH

Relative Price Performance (Last 90 Days)

ARQ 1M: -11.5% · 3M: -12.2% ASTH 1M: -27.0% · 3M: +2.9%

Current Technical Phase

ARQ

Markdown
Sell / avoid

Price below a falling SMA50 (slope -5.6%), weak momentum, RSI 39

RSI (14): 39.2 · Price: $2.01

ASTH

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 30

RSI (14): 29.9 · Price: $35.91

Fundamentals Snapshot

Metric ARQ ASTH
Market Cap
Forward P/E -28.7 10.5
Trailing P/E 58.3
Revenue (TTM)
Revenue Growth 0.1% 0.6%
Gross Margin 0.3% 0.1%
Operating Margin 0.0% 0.0%
EPS -1.29 0.61
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, ASTH is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.